Siga Technologies (SIGA) Non Operating Income (2010 - 2025)
Siga Technologies' (SIGA) quarterly Non Operating Income came in at $1.9 million in Q3 2025, up 40.3% on a YoY basis from $1.3 million in Q3 2024, and up 17.23% quarter-over-quarter from $1.6 million in Q2 2025.
Analysis
Siga Technologies (SIGA) Non Operating Income (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Non Operating Income for 16 consecutive years, with $1.9 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Non Operating Income rose 40.3% year-over-year to $1.9 million; the trailing twelve-month figure through Sep 2025 stood at $6.7 million (up 14.19% YoY), and the FY2024 full-year result was $6.1 million, up 45.24% from the prior year.
- Non Operating Income climbed to $1.9 million in Q3 2025 per SIGA's latest filing, from $1.6 million in the prior quarter.
- Across five years, Non Operating Income topped out at $1.9 million in Q1 2024 and bottomed at $23322.0 in Q1 2022.
- Historically, Non Operating Income has averaged $889464.5 across 5 years, with a median of $1.0 million in 2022.
- The sharpest annual moves came in 2021 and 2022: Non Operating Income plunged 93.8% in 2021, then surged 3881.37% in 2022.
- Over 5 years, Non Operating Income stood at $25117.0 in 2021, then soared by 3881.37% to $1.0 million in 2022, then climbed by 23.55% to $1.2 million in 2023, then gained by 22.14% to $1.5 million in 2024, then increased by 23.7% to $1.9 million in 2025.
- According to Business Quant data, Non Operating Income over the past three periods registered $1.9 million, $1.6 million, and $1.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -139.24 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 41.90 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 883,148.00 |
| Jun 30, 2023 | 1.19 Mn |
| Mar 31, 2023 | 890,629.00 |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 258,975.00 |
| Jun 30, 2022 | 72,373.00 |
| Mar 31, 2022 | 23,322.00 |
| Dec 31, 2021 | 25,117.00 |
| Sep 30, 2021 | 26,252.00 |
| Jun 30, 2021 | 24,235.00 |
| Mar 31, 2021 | 25,568.00 |
| Dec 31, 2020 | 62,859.00 |